Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Therapeutics symbols : Cyto save search
Altamira Therapeutics Provides Business Update, Reports Full Year 2023 Financial Results
Published: 2024-04-10 (Crawled : 12:00) - globenewswire.com
CYTO | $1.66 -9.29% -8.93% 5.5K
|
Manufacturing
|
| O: -5.56%
H: 7.49%
C: 6.95%
business year therapeutics financial results
Altamira Therapeutics to Host Full Year 2023 Financial Results and Business Update Call on April 10, 2024
Published: 2024-04-04 (Crawled : 12:30) - globenewswire.com
CYTO | $1.66 -9.29% -8.93% 5.5K
|
Manufacturing
|
| O: 4.21%
H: 5.56%
C: 5.56%
business year update therapeutics financial results
Altamira Therapeutics Announces Collaboration with Univercells Group on Nanoparticle-Delivered mRNA Vaccines
Published: 2024-03-25 (Crawled : 13:00) - globenewswire.com
CYTO | $1.66 -9.29% -8.93% 5.5K
|
Manufacturing
|
| O: 83.24%
H: 10.09%
C: -25.87%
mrna group collaboration therapeutics
Altamira Therapeutics Files Second Provisional Patent Application for OligoPhore Nanoparticles Targeting Different KRAS Mutations in Cancer Treatment
Published: 2024-01-24 (Crawled : 14:00) - globenewswire.com
CYTO | $1.66 -9.29% -8.93% 5.5K
|
Manufacturing
|
| O: 21.43%
H: 1.52%
C: -10.59%
patent cancer treatment application therapeutics
Altamira Therapeutics to Present at 3rd Annual mRNA-Based Therapeutics Summit
Published: 2024-01-08 (Crawled : 14:00) - globenewswire.com
CYTO | $1.66 -9.29% -8.93% 5.5K
|
Manufacturing
|
| O: 3.21%
H: 0.0%
C: -3.11%
therapeutics
Altamira Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement
Published: 2023-12-29 (Crawled : 14:00) - globenewswire.com
CYTO | $1.66 -9.29% -8.93% 5.5K
|
Manufacturing
|
| O: -1.54%
H: 10.66%
C: 9.09%
nasdaq therapeutics
Altamira Therapeutics Provides Investor and Business Update
Published: 2023-12-11 (Crawled : 13:00) - globenewswire.com
CYTO | $1.66 -9.29% -8.93% 5.5K
|
Manufacturing
|
| O: -49.01%
H: 23.92%
C: -9.38%
business update therapeutics
Altamira Therapeutics to Host Investor & Business Update Call on December 11th
Published: 2023-12-05 (Crawled : 18:00) - globenewswire.com
CYTO | $1.66 -9.29% -8.93% 5.5K
|
Manufacturing
|
| O: 3.81%
H: 29.75%
C: 14.56%
business update therapeutics
Altamira Therapeutics Regains Compliance with Nasdaq Minimum Stockholders' Equity Requirement
Published: 2023-11-29 (Crawled : 15:30) - globenewswire.com
CYTO | $1.66 -9.29% -8.93% 5.5K
|
Manufacturing
|
| O: -8.57%
H: 242.37%
C: 206.47%
nasdaq therapeutics
Altamira Therapeutics Announces Partial Spin-Off of Bentrio® Business
Published: 2023-11-17 (Crawled : 14:00) - globenewswire.com
CYTO | $1.66 -9.29% -8.93% 5.5K
|
Manufacturing
|
| O: 55.66%
H: 207.4%
C: 80.06%
bentrio business therapeutics
Altamira Therapeutics Announces European Patent Office Decision to Grant for Patent Application Covering Intranasal Betahistine
Published: 2023-11-10 (Crawled : 13:30) - globenewswire.com
CYTO | $1.66 -9.29% -8.93% 5.5K
|
Manufacturing
|
| O: 9.92%
H: 0.0%
C: -19.26%
patent grant application therapeutics
Altamira Therapeutics Reports Additional Significant Efficacy Outcomes from Bentrio Clinical Trial in Seasonal Allergic Rhinitis
Published: 2023-09-14 (Crawled : 12:30) - globenewswire.com
CYTO | $1.66 -9.29% -8.93% 5.5K
|
Manufacturing
|
| O: 23.91%
H: 11.41%
C: -23.91%
trial therapeutics
Altamira Therapeutics Provides Business Update and First Half 2023 Financial Results
Published: 2023-09-12 (Crawled : 12:00) - globenewswire.com
CYTO | $1.66 -9.29% -8.93% 5.5K
|
Manufacturing
|
| O: -3.53%
H: 0.61%
C: -2.59%
business update therapeutics financial results
Altamira Therapeutics to Host First Half 2023 Financial Results and Business Update Call on September 12th
Published: 2023-09-06 (Crawled : 13:00) - globenewswire.com
CYTO | $1.66 -9.29% -8.93% 5.5K
|
Manufacturing
|
| O: 0.0%
H: 2.26%
C: -0.2%
business update therapeutics financial results
Altamira Therapeutics to Present at H.C. Wainwright 25th Annual Global Investment Conference September 11-13
Published: 2023-08-23 (Crawled : 12:30) - globenewswire.com
CYTO | $1.66 -9.29% -8.93% 5.5K
|
Manufacturing
|
| O: 2.5%
H: 0.27%
C: -2.71%
conference global therapeutics
Altamira Therapeutics and Pharma Nordic Collaborate for Marketing and Distribution of Bentrio in Scandinavia
Published: 2023-07-20 (Crawled : 13:00) - globenewswire.com
CYTO | $1.66 -9.29% -8.93% 5.5K
|
Manufacturing
|
| O: 0.74%
H: 3.52%
C: -0.51%
pharma distribution therapeutics
Altamira Therapeutics Announces Publication of Positive Results from Clinical Trial with Bentrio in House Dust Mite Allergy in Leading Peer Reviewed Journal
Published: 2023-07-17 (Crawled : 13:00) - globenewswire.com
CYTO | $1.66 -9.29% -8.93% 5.5K
|
Manufacturing
|
| O: 6.09%
H: 0.12%
C: -9.89%
positive publication trial therapeutics results house
Altamira Therapeutics Announces Pricing of $5.0 Million Public Offering
Published: 2023-07-06 (Crawled : 14:20) - biospace.com/
CYTO | $1.66 -9.29% -8.93% 5.5K
|
Manufacturing
|
| O: -13.94%
H: 11.68%
C: 5.96%
offering therapeutics
Altamira Therapeutics Announces Collaboration with Heqet Therapeutics on Nanoparticle-Delivered Non-Coding RNAs for Cardiac Regeneration
Published: 2023-07-05 (Crawled : 13:00) - globenewswire.com
CYTO | $1.66 -9.29% -8.93% 5.5K
|
Manufacturing
|
| O: -3.45%
H: 13.7%
C: -3.36%
cardiac collaboration therapeutics
Altamira Therapeutics Reports Positive Top-Line Data from Bentrio Clinical Trial in Seasonal Allergic Rhinitis
Published: 2023-05-24 (Crawled : 15:00) - biospace.com/
CYTO | $1.66 -9.29% -8.93% 5.5K
|
Manufacturing
|
| O: 33.72%
H: 2.61%
C: -23.65%
positive trial therapeutics
Gainers vs Losers
| 28% | 72% |
Top 10 Gainers
AMPL | $9.83 2.08% 2.7K
|
CL | $86.445 0.32% 43K
|
Consumer Non-Durables
AESI | $22.105 0.11% 4.7K
|
n/a
AJG | $232.2 0.05% 11K
|
Finance
EXPE 4 | $128.72 0.05% 18K
|
Consumer Services
BCAB | $2.86 3.6K
|
DTE | $105.365 -0.15% 5.1K
|
Utilities
AME | $178.705 -0.19% 9.1K
|
Producer Manufacturing
ESTC 4 | $94.65 -0.21% 9.2K
|
Technology Services
EXC 4 | $36.19 -0.22% 48K
|
Utilities
Your saved searches
Save your searches and get alerts when important news are released.